Zobrazeno 1 - 10
of 194
pro vyhledávání: '"Eisuke, Adachi"'
Autor:
Wakana Sato, Ayako Sedohara, Michiko Koga, Yu Nakagama, Hiroshi Yotsuyanagi, Yasutoshi Kido, Eisuke Adachi
Publikováno v:
AIDS Research and Therapy, Vol 21, Iss 1, Pp 1-9 (2024)
Abstract Background The challenges in culturing Treponema pallidum have hindered molecular-biological analysis. This study aims to establish a molecular epidemiological analysis of syphilis among Japanese men who have sex with men (MSM) and to invest
Externí odkaz:
https://doaj.org/article/1198ea87fa524e73b3c2d81c124e366e
Autor:
Eisuke Adachi, Ayako Sedohara, Kotaro Arizono, Kazuaki Takahashi, Amato Otani, Yoshiaki Kanno, Makoto Saito, Michiko Koga, Hiroshi Yotsuyanagi
Publikováno v:
Emerging Infectious Diseases, Vol 30, Iss 8, Pp 1668-1671 (2024)
A patient in Japan with HIV began antiretroviral therapy because of acute hepatitis B virus (HBV) 15 years ago, with low hepatitis B surface antibody, and experienced breakthrough HBV reactivation 4 months after switching from bictegravir/emtricitabi
Externí odkaz:
https://doaj.org/article/f3596203bc334055af7e5e948dca643e
Autor:
Tetiana Yatsenko, Ricardo Rios, Tatiane Nogueira, Yousef Salama, Satoshi Takahashi, Eisuke Adachi, Yoko Tabe, Nobutaka Hattori, Taro Osada, Toshio Naito, Kazuhisa Takahashi, Koichi Hattori, Beate Heissig
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionPlasminogen activator inhibitor-1 (PAI-1) is linked to thrombosis and endothelial dysfunction in severe COVID-19. The +43 G>A PAI-1 and 4G/5G promoter polymorphism can influence PAI-1 expression. The 4G5G PAI-1 promoter gene polymorphism
Externí odkaz:
https://doaj.org/article/178b685b095a4c2ab5416ac98fd1b9e9
Autor:
Aya Ishizaka, Michiko Koga, Taketoshi Mizutani, Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Eisuke Adachi, Yutaka Suzuki, Yoshihiro Kawaoka, Hiroshi Yotsuyanagi
Publikováno v:
BMC Microbiology, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background People living with HIV (PLWH) with chronic inflammation may have an increasing risk for coronavirus disease 2019 (COVID-19) severity; however, the impact of their gut microbiota on COVID-19 is not fully elucidated. Here, we analyz
Externí odkaz:
https://doaj.org/article/77d1edc4399a421982cd88866ec3457a
Publikováno v:
AIDS Research and Therapy, Vol 21, Iss 1, Pp 1-6 (2024)
Abstract We assessed whether the impact of cabotegravir plus rilpivirine on inflammation reduction differs from that of oral antiretrovirals, using real-world data. Inflammatory biomarkers and lipid profiles were followed from baseline to 8 months af
Externí odkaz:
https://doaj.org/article/9818fe37887d4f2ab1a788ea7801c4a1
Autor:
Ryuta Uraki, Mutsumi Ito, Maki Kiso, Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Yuko Sakai-Tagawa, Masaki Imai, Michiko Koga, Shinya Yamamoto, Eisuke Adachi, Makoto Saito, Takeya Tsutsumi, Amato Otani, Shuetsu Fukushi, Shinji Watanabe, Tadaki Suzuki, Tetsuhiro Kikuchi, Hiroshi Yotsuyanagi, Ken Maeda, Yoshihiro Kawaoka
Publikováno v:
iScience, Vol 26, Iss 11, Pp 108147- (2023)
Summary: The emergence and spread of new SARS-CoV-2 variants with mutations in the spike protein, such as the XBB.1.5 and XBB.1.9.1 sublineages, raise concerns about the efficacy of current COVID-19 vaccines and therapeutic monoclonal antibodies (mAb
Externí odkaz:
https://doaj.org/article/bcc9e8dce069400aa6ad9a843503c254
Autor:
Shinya Yamamoto, Seiya Yamayoshi, Mutsumi Ito, Yuko Sakai-Tagawa, Ichiro Nakachi, Rie Baba, Shigenobu Kamimoto, Takayuki Ogura, Shigehiro Hagiwara, Hideaki Kato, Hideaki Nakajima, Yoshifumi Uwamino, Kazuma Yagi, Norio Sugaya, Hiroyuki Nagai, Makoto Saito, Eisuke Adachi, Michiko Koga, Takeya Tsutsumi, Calvin Duong, Moe Okuda, Jurika Murakami, Yuri Furusawa, Michiko Ujie, Kiyoko Iwatsuki-Horimoto, Hiroshi Yotsuyanagi, Yoshihiro Kawaoka
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107208- (2023)
Summary: SARS-CoV-2 has gradually acquired amino acid substitutions in its S protein that reduce the potency of neutralizing antibodies, leading to decreased vaccine efficacy. Here, we attempted to obtain mutant viruses by passaging SARS-CoV-2 in the
Externí odkaz:
https://doaj.org/article/517adb32d19c447b88d368466fbef197
Autor:
Ryuta Uraki, Mutsumi Ito, Maki Kiso, Seiya Yamayoshi, Kiyoko Iwatsuki-Horimoto, Yuko Sakai-Tagawa, Masaki Imai, Michiko Koga, Shinya Yamamoto, Eisuke Adachi, Makoto Saito, Takeya Tsutsumi, Amato Otani, Yukie Kashima, Tetsuhiro Kikuchi, James Theiler, Hiroshi Yotsuyanagi, Yutaka Suzuki, Bette Korber, Yoshihiro Kawaoka
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 34, Iss , Pp 100777- (2023)
Externí odkaz:
https://doaj.org/article/ec0c5a54a52844b684c4e8b1be490ce3
Autor:
Kazuhiko Ikeuchi, Kazuya Okushin, Makoto Saito, Eisuke Adachi, Takeya Tsutsumi, Tomoyuki Takura, Hiroshi Yotsuyanagi
Publikováno v:
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Hepatitis C virus (HCV) has been mainly transmitted through injection drug use, but recently, sexual transmission among men who have sex with men (MSM), which is also a major route of HIV transmission, is increasing. However, the
Externí odkaz:
https://doaj.org/article/d19c1e136e4c42e39efd1fe6b990a39c
Autor:
Koichi Kimura, Eisuke Adachi, Sachie Omori, Ayako Toyohara, Takahiro Higashi, Kippei Ohgaki, Shuhei Ito, Shin-ichiro Maehara, Toshihiko Nakamura, Yoichi Ikeda, Yoshihiko Maehara
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Percutaneous transhepatic gallbladder drainage (PTGBD) is recommended for acute cholecystitis patients at high risk for surgical treatment. However, there is no evidence about the best timing of surgery after PTGBD. Here, we retro
Externí odkaz:
https://doaj.org/article/75a0da237de04ed3831a16be66d02821